Big Pharma Might Be Getting an Early Christmas Present
Good morning, readers.
This is Sy taking over for Cliff today. He’s currently in Rome for the Fortune and Time Global Forum, where he’ll be discussing public health with 100 CEOs and world leaders—including Dr. Raj Panjabi, who just won the $1 million 2017 TED Prize for his work in public health. See my write-up below for more details.
We’ve got plenty to discuss over on this continent, too—on the legislative, clinical, and business sides alike. Just last night, Congress took a big step towards passing the pharma-backed 21st Century Cures Act, which is the most far-reaching healthcare reform bill since Obamacare and carries major implications for drug approvals, the U.S. mental health system, and scientific research; a biotech firm announced extremely promising initial trial results for a type of next-gen cancer therapy which has faced some recent disappointments; and a certain supercomputer is teaming up with an American pharma giant to advance cancer immunotherapy.
Read on for the day’s news.